$0.296900
-0.0044-1.48%
At close: Jul 1, 7:25 PM EDT
$0.292500
-0.0044-1.48%
After Hours: 7:25 PM EDT
15 minutes delayed
Lyra Therapeutics
LYRANASDAQ
Lyra Therapeutics (NASDAQ:LYRA) Stock, Earnings Estimates, EPS, And Revenue
Lyra Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 6
EPS Estimate
$-0.280
Quarterly Revenue Estimate
$360K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$1.7M
Analyze the earnings history of Lyra Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LYRA | Lyra Therapeutics | -$0.36 | -$0.28 | — | — | $458.00K | $360.00K | — | — | 08/06/2024 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.44 | -$0.26 | -$0.35 | -34.62% | $410.00K | $420.00K | $532.00K | 26.67% | 04/30/2024 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.32 | -$0.31 | -$0.22 | 29.03% | $11.00K | $390.00K | $146.00K | -62.56% | 03/21/2024 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.40 | -$0.32 | -$0.27 | 15.62% | $359.00K | $370.00K | $544.00K | 47.03% | 11/07/2023 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.43 | -$0.42 | -$0.36 | 14.29% | $407.00K | $140.00K | $458.00K | 227.14% | 08/08/2023 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.92 | -$0.36 | -$0.44 | -22.22% | $468.00K | $160.00K | $410.00K | 156.25% | 05/12/2023 | Get Alert |
| LYRA | Lyra Therapeutics | -$1.05 | -$0.41 | -$0.32 | 21.95% | $271.00K | $150.00K | $11.00K | -92.67% | 03/29/2023 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.85 | -$0.44 | -$0.40 | 9.09% | $14.00K | $140.00K | $359.00K | 156.43% | 11/08/2022 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.85 | -$0.37 | -$0.43 | -16.22% | $0.00 | $1.44M | $407.00K | -71.74% | 08/09/2022 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.60 | -$0.91 | -$0.54 | 40.66% | $0.00 | $1.25M | $5.37M | 329.36% | 05/10/2022 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.46 | -$0.97 | -$1.05 | -8.25% | $0.00 | — | $271.00K | — | 03/09/2022 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.49 | -$0.73 | -$0.85 | -16.44% | $0.00 | — | $14.00K | — | 11/09/2021 | Get Alert |
| LYRA | Lyra Therapeutics | -$0.56 | -$0.59 | -$0.85 | -44.07% | $0.00 | — | $0.00 | — | 08/09/2021 | Get Alert |
| LYRA | Lyra Therapeutics | -$18.70 | -$0.48 | -$0.60 | -25.00% | $0.00 | — | $0.00 | — | 05/11/2021 | Get Alert |
| LYRA | Lyra Therapeutics | — | -$0.56 | -$0.46 | 17.86% | — | — | $0.00 | — | 03/09/2021 | Get Alert |
| LYRA | Lyra Therapeutics | — | — | -$0.49 | — | — | — | $0.00 | — | 11/10/2020 | Get Alert |
| LYRA | Lyra Therapeutics | — | -$0.38 | -$0.56 | -47.37% | — | — | $0.00 | — | 08/05/2020 | Get Alert |
| LYRA | Lyra Therapeutics | — | — | -$18.70 | — | — | — | $0.00 | — | 05/28/2020 | Get Alert |
Lyra Therapeutics (LYRA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-30 | $-0.35 | $-0.26 | -34.6 % |
| Dec 2023 | 2024-03-21 | $-0.22 | $-0.31 | 29.0 % |
| Sep 2023 | 2023-11-07 | $-0.27 | $-0.32 | 15.6 % |
| Jun 2023 | 2023-08-08 | $-0.36 | $-0.42 | 14.3 % |
Lyra Therapeutics (LYRA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-04-30 | $532.00K | $420.00K | 26.7 % |
| Dec 2023 | 2024-03-21 | $146.00K | $390.00K | -62.6 % |
| Sep 2023 | 2023-11-07 | $544.00K | $370.00K | 47.0 % |
| Jun 2023 | 2023-08-08 | $458.00K | $140.00K | 227.1 % |
FAQ
When is Lyra Therapeutics (NASDAQ:LYRA) reporting earnings?
Lyra Therapeutics (LYRA) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on April 30, 2024 for Q1.
What were the latest earnings per share (EPS) for Lyra Therapeutics (NASDAQ:LYRA)?
The Actual EPS was $-0.35, which missed the estimate of $-0.26.
What were Lyra Therapeutics’s (NASDAQ:LYRA) revenues?
The Actual Revenue was $532K, which beat the estimate of $420K.
Browse earnings estimates, EPS, and revenue on all stocks.